Investment Management Corp of Ontario (IMCO)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Sell
9,334
-1,200
-11% -$230K 0.03% 419
2026
Q1
$1.93M Sell
10,534
-1,808
-15% -$333K 0.02% 434
2025
Q4
$2.17M Buy
12,342
+2,955
+31% +$483K 0.03% 410
2025
Q3
$1.31M Buy
9,387
+3,309
+54% +$447K 0.02% 414
2025
Q2
$763K Sell
6,078
-500
-8% -$62.3K 0.01% 450
2025
Q1
$900K Buy
6,578
+2,508
+62% +$359K 0.02% 421
2024
Q4
$622K Sell
4,070
-800
-16% -$135K 0.02% 272
2024
Q3
$944K Buy
4,870
+1,600
+49% +$335K 0.02% 413
2024
Q2
$758K Buy
3,270
+900
+38% +$196K 0.02% 379
2024
Q1
$511K Sell
2,370
-18,187
-88% -$4.26M 0.02% 418
2023
Q4
$5.32M Buy
+20,557
New +$5.05M 0.13% 131

Other funds holding BIIB

Investment Management Corp of Ontario (IMCO)'s BIIB Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Biogen (BIIB) stake by 11% in Q2 2026, selling an estimated $230K and leaving 9,334 shares worth $2.02M. The position accounts for 0.03% of the portfolio, ranked #419.

Investment Management Corp of Ontario (IMCO) first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.32M in Q4 2023. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 9,334 shares of Biogen worth $2.02M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 1,200 Biogen shares in Q2 2026, an estimated $230K.
  • Biogen made up 0.03% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #419 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • Investment Management Corp of Ontario (IMCO)'s Biogen position peaked at $5.32M in Q4 2023.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.